Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
Open accessAbstract
Regulated by histone acetyltransferases and deacetylases (HDACs), histone acetylation is a key epigenetic mechanism controlling chromatin structure, DNA accessibility, and gene expression. HDAC inhibitors induce growth arrest, differentiation, and apoptosis of tumor cells and are used as anticancer agents. Here we describe the effects of HDAC inhibitors on microbial sensing by macrophages and dendritic cells in vitro and host defenses against infection in vivo. HDAC inhibitors down-regulated the expression of numerous host defense genes, including pattern recognition receptors, kinases, transcription regulators, cytokines, chemokines, growth factors, and costimulatory molecules as assessed by genome-wide microarray analyses or innate immune responses of macrophages and dendritic cells stimulated with Toll-like receptor agonists. HDAC inhibitors induced the expression of Mi-2β and enhanced the DNA-binding activity of the Mi-2/NuRD complex that acts as a transcriptional repressor of macrophage cytokine production. In vivo, HDAC inhibitors increased the susceptibility to bacterial and fungal infections but conferred protection against toxic and septic shock. Thus, these data identify an essential role for HDAC inhibitors in the regulation of the expression of innate immune genes and host defenses against microbial pathogens.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Drug inhibition of cellular deacetylases strongly attenuates pathogen- and immunogen-induced immune responses.
“As drug inhibition of cellular deacetylases strongly attenuates pathogen-and immunogen-induced immune responses (139–141), it is tempting to speculate that acetylation plays a key role in modulating immune signaling pathways.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Delaloye, J., Roger, T., Steiner, Q., Roy, D. L., Reymond, M. K., Akira, S., Pétrilli, V., Gómez, C. E., Perdiguero, B., Tschopp, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000480 · Cited by 307 · see citing works
Self-citationRetractedKorn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · see citing works
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1001 · Cited by 3,933 · see citing works
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · see citing works
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862 · see citing works
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,541 · see citing works
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782 · see citing works
Self-citationHistone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542 · see citing works
Extracellular histones are major mediators of death in sepsis
Xu, J., Zhang, X., Pelayo, R., Monestier, M., Ammollo, C. T., Semeraro, F., Taylor, F. B., Esmon, N. L., Lupu, F., & Esmon, C. T. (2009) · Nature Medicine · doi:10.1038/nm.2053 · Cited by 1,540 · see citing works
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,239 · see citing works
Harmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2402 · Cited by 1,199 · see citing works
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,198 · see citing works
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccalà, R., Beutler, B., & Kono, D. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185 · see citing works
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154 · see citing works
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031 · see citing works
Kelly, W. K., O’Connor, O. A., Krug, L. M., Chiao, J. H., Heaney, M. L., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Secrist, J. P., Schwartz, L. B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.167 · Cited by 906 · see citing works
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 753 · see citing works
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736 · see citing works
MIF regulates innate immune responses through modulation of Toll-like receptor 4
Roger, T., David, J. R., Glauser, M. P., & Calandra, T. (2001) · Nature · doi:10.1038/414920a · Cited by 584 · see citing works
Self-citationHost–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 552 · see citing works
Host Innate Immune Receptors and Beyond: Making Sense of Microbial Infections
Ishii, K. J., Koyama, S., Nakagawa, A., Coban, C., & Akira, S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.003 · Cited by 501 · see citing works
Ramirez-Carrozzi, V., Nazarian, A. A., Li, C.-Y. C., Gore, S., Sridharan, R., Imbalzano, A., & Smale, S. (2006) · Genes & Development · doi:10.1101/gad.1383206 · Cited by 456 · see citing works
Ryan, Q. C., Headlee, D. J., Acharya, M. R., Sparreboom, A., Trepel, J. B., Ye, Z., Figg, W. D., Hwang, K., Chung, E. J., Murgo, A. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.188 · Cited by 412 · see citing works
Clinical Studies of Histone Deacetylase Inhibitors
Prince, H. M., Bishton, M. J., & Harrison, S. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2785 · Cited by 358 · see citing works
Nusinzon, I., & Horvath, C. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2433987100 · Cited by 307 · see citing works
Gojo, I., Jiemjit, A., Trepel, J. B., Sparreboom, A., Figg, W. D., Rollins, S., Tidwell, M. L., Greer, J. M., Chung, E. J., Lee, M.-J., et al. (2006) · Blood · doi:10.1182/blood-2006-05-021873 · Cited by 281 · see citing works
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Wallis, R. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70227-5 · Cited by 275 · see citing works
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
Roger, T., Froidevaux, C., Roy, D. L., Reymond, M. K., Chanson, A.-L., Mauri, D., Burns, K., Riederer, B. M., Akira, S., & Calandra, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808146106 · Cited by 267 · see citing works
Self-citationReddy, P. R., Sun, Y., Toubai, T., Duran‐Struuck, R., Clouthier, S. G., Weisiger, E., Maeda, Y., Tawara, I., Krijanovski, O. I., Gatza, E., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34712 · Cited by 264 · see citing works
Candelaria, M., Gallardo‐Rincón, D., Arce, C., Cetina, L., Aguilar-Ponce, J. L., Arrieta, O. G., González‐Fierro, A., Chávez-Blanco, A. D., de la Cruz-Hernandez, E., Camargo, M. F. V. C., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm204 · Cited by 252 · see citing works
Aung, H. T., Schroder, K., Himes, S. R., Brion, K., van Zuylen, W. J., Trieu, A., Suzuki, H., Hayashizaki, Y., Hume, D. A., Sweet, M. J., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5360com · Cited by 229 · see citing works
Brogdon, J. L., Xu, Y., Szabo, S. J., An, S., Buxton, F., Cohen, D., & Huang, Q. (2006) · Blood · doi:10.1182/blood-2006-04-019711 · Cited by 226 · see citing works
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling
Cao, W., Bao, C., Padalko, E. Y., & Lowenstein, C. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071728 · Cited by 188 · see citing works
Roger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184 · see citing works
Self-citationBode, K. A., Schroder, K., Hume, D. A., Ravasi, T., Heeg, K. M., Sweet, M. J., & Dalpke, A. H. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02678.x · Cited by 180 · see citing works
The role of type I interferons in non‐viral infections
Bogdan, C., Mattner, J., & Schleicher, U. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00207.x · Cited by 178 · see citing works
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604958200 · Cited by 153 · see citing works
A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code
Calao, M., Burny, A., Quivy, V., Dekoninck, A., & Lint, C. M. V. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.04.015 · Cited by 139 · see citing works
Nusinzon, I., & Horvath, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3106-3113.2006 · Cited by 139 · see citing works
Galli, M., Salmoiraghi, S., Golay, J., Gozzini, A., Crippa, C., Pescosta, N., & Rambaldi, A. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0793-8 · Cited by 101 · see citing works
Reilly, C. M., Thomas, M. R., Gogal, R. M., Olgun, S., Santo, A., Sodhi, R., Samy, E. T., Peng, S. L., Gilkeson, G. S., & Mishra, N. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.04.020 · Cited by 99 · see citing works
Roy, D. L., Padova, F. D., Adachi, Y., Glauser, M. P., Calandra, T., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2759 · Cited by 94 · see citing works
Self-citationA BAF-centred view of the immune system
Chi, T. H. (2004) · Nature reviews. Immunology · doi:10.1038/nri1501 · Cited by 84 · see citing works
Rocca, A., Minucci, S., Tosti, G., Croci, D., Contegno, F., Ballarini, M., Nolè, F., Munzone, E., Salmaggi, A., Goldhirsch, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604817 · Cited by 79 · see citing works
Cytokines as Therapeutic Targets: Advances and Limitations
Scheinecker, C., Redlich, K., & Smolen, J. S. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.005 · Cited by 78 · see citing works
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo
Bosisio, D., Vulcano, M., Prete, A. D., Sironi, M., Salvi, V., Salogni, L., Riboldi, E., Leoni, F., Dinarello, C. A., Girolomoni, G., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708401 · Cited by 72 · see citing works
Lu, X., Kovalev, G. I., Chang, H., Kallin, E. M., Knudsen, G., Li, X., Mishra, N., Ruiz, P., Li, E., Su, L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801275200 · Cited by 63 · see citing works
Lugrin, J., Ding, X. C., Roy, D. L., Chanson, A.-L., Sweep, F. C. G. J., Calandra, T., & Roger, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.007 · Cited by 51 · see citing works
Self-citationMiconnet, I., & Pantaleo, G. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.028 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
1 of the 51 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322269111 · Cited by 2,175 · see citing works
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536 · see citing works
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,445 · see citing works
The role of short-chain fatty acids in immunity, inflammation and metabolism
Yao, Y., Cai, X. T., Fei, W., Ye, Y., Zhao, M., & Zheng, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1854675 · Cited by 776 · see citing works
Amino Assets: How Amino Acids Support Immunity
Kelly, B. L., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 653 · see citing works
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 622 · see citing works
Histone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546 · see citing works
Gut Bacteria and Neurotransmitters
Dicks, L. M. T. (2022) · Microorganisms · doi:10.3390/microorganisms10091838 · Cited by 482 · see citing works
Regulation of short-chain fatty acids in the immune system
Liu, X., Shao, J.-H., Liao, Y.-T., Wang, L., Yuan, J., Dong, P.-J., Liu, Z., He, D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 435 · see citing works
Epigenetic regulation of macrophage polarization and function
Ivashkiv, L. B. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.11.001 · Cited by 396 · see citing works
Gonçalves, P., Araújo, J. R., & Santo, J. P. D. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 396 · see citing works
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 332 · see citing works
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314 · see citing works
HDAC inhibitor‐based therapies: Can we interpret the code?
New, M. I., Olzscha, H., & Thangue, N. B. L. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.003 · Cited by 310 · see citing works
Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators
Kaliman, P., Álvarez-López, M. J., Cosín-Tomás, M., Rosenkranz, M. A., Lutz, A., & Davidson, R. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.004 · Cited by 300 · see citing works
Wei, D. G., Chiang, V., Fyne, E., Balakrishnan, M., Barnes, T. L., Graupe, M., Hesselgesser, J., Irrinki, A., Murry, J. P., Stepan, G. J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004071 · Cited by 272 · see citing works
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
Wyngene, L. V., Vandewalle, J., & Libert, C. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708712 · Cited by 264 · see citing works
Saleh, H. A., Yousef, M., & Abdelnaser, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606069 · Cited by 204 · see citing works
Zinc binding groups for histone deacetylase inhibitors
Zhang, L., Zhang, J., Jiang, Q., Zhang, L., & Song, W. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1417274 · Cited by 240 · see citing works
Jain, N., Moeller, J., & Vogel, V. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121224 · Cited by 237 · see citing works
Myeloid-Derived Suppressor Cells in Sepsis
Schrijver, I. T., Théroude, C., & Roger, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00327 · Cited by 224 · see citing works
Self-citationRegulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate
Thio, C. L., Chi, P., Lai, A. C., & Chang, Y. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.032 · Cited by 218 · see citing works
Grabiec, A. M., Korchynskyi, O., Tak, P. P., & Reedquist, K. A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154211 · Cited by 211 · see citing works
Histone deacetylases as targets for treatment of multiple diseases
Tang, J., Yan, H., & Zhuang, S. (2013) · Clinical Science · doi:10.1042/cs20120504 · Cited by 204 · see citing works
(ECIL), O. B. O. T. E. C. O. I. I. L., Maschmeyer, G., Greef, J. D., Mellinghoff, S. C., Nosari, A., Thiébaut, A., Bergeron, A., Franquet, T., Blijlevens, N. M. A., & Maertens, J. A. (2019) · Leukemia · doi:10.1038/s41375-019-0388-x · Cited by 184 · see citing works
Emerging roles of lactate in acute and chronic inflammation
Fang, Y., Li, Z., Yang, L., Li, W., Wang, Y., Kong, Z., Miao, J., Chen, Y., Bian, Y., & Zeng, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01624-8 · Cited by 181 · see citing works
HDAC inhibitors and immunotherapy; a double edged sword?
Kroesen, M., Gielen, P. R., Brok, I. C., Armandari, I., Hoogerbrugge, P. M., & Adema, G. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2289 · Cited by 167 · see citing works
Sanford, J. A., Zhang, L.-J., Williams, M. R., Gangoiti, J. A., Huang, C.-M., & Gallo, R. L. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah4609 · Cited by 166 · see citing works
HDAC inhibitors in parasitic diseases
Andrews, K. T., Haque, A., & Jones, M. K. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.97 · Cited by 165 · see citing works
Magnusson, M. K., Strid, H., Sapnara, M., Lasson, A., Bajor, A., Ung, K., & Öhman, L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw051 · Cited by 164 · see citing works
Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer
Dinarello, C. A., Fossati, G., & Mascagni, P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00116 · Cited by 160 · see citing works
Dichotomous engagement of HDAC3 activity governs inflammatory responses
Nguyen, H. C. B., Adlanmerini, M., Hauck, A. K., & Lazar, M. A. (2020) · Nature · doi:10.1038/s41586-020-2576-2 · Cited by 150 · see citing works
Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
Mazzone, R., Zwergel, C., Mai, A., & Valente, S. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0358-y · Cited by 150 · see citing works
Daskalaki, M., Tsatsanis, C., & Kampranis, S. C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26497 · Cited by 137 · see citing works
Giannoni, É., Guignard, L., Reymond, M. K., Perreau, M., Roth‐Kleiner, M., Calandra, T., & Roger, T. (2011) · Infection and Immunity · doi:10.1128/iai.00076-11 · Cited by 135 · see citing works
Self-citationRegulatory dendritic cells in autoimmunity: A comprehensive review
Liu, J., & Cao, X. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.011 · Cited by 133 · see citing works
White, C. A., Pone, E. J., Lam, T., Tat, C., Hayama, K. L., Li, G., Zan, H., & Casali, P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401702 · Cited by 131 · see citing works
Zhang, L., Han, Y., Jiang, Q., Wang, C., Chen, X., Li, X., Xu, F., Jiang, Y., Wang, Q., & Xu, W. (2014) · Medicinal Research Reviews · doi:10.1002/med.21320 · Cited by 130 · see citing works
Leishmania donovani Infection Causes Distinct Epigenetic DNA Methylation Changes in Host Macrophages
Marr, A. K., MacIsaac, J. L., Jiang, R., Airo, A. M., Kobor, M. S., & McMaster, W. R. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004419 · Cited by 126 · see citing works
Lovatel, G. A., Elsner, V. R., Bertoldi, K., Vanzella, C., Moysés, F. D. S., Vizuete, A. F. K., Spindler, C. D. F., Cechinel, L. R., Netto, C. A., Muotri, A. R., et al. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.01.007 · Cited by 126 · see citing works
Sanford, J. A., O’Neill, A. M., Zouboulis, C. C., & Gallo, R. L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800893 · Cited by 125 · see citing works
Jurdzinski, K. T., Potempa, J., & Grabiec, A. M. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00982-7 · Cited by 126 · see citing works
Epigenetic regulation of macrophage polarization in wound healing
Chen, C., Liu, T., Tang, Y., Luo, G., Liang, G., & He, W. (2023) · Burns & Trauma · doi:10.1093/burnst/tkac057 · Cited by 123 · see citing works
Cellular metabolism of myeloid cells in sepsis
Arts, R. J. W., Gresnigt, M. S., Joosten, L. A. B., & Netea, M. G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0216-066r · Cited by 120 · see citing works
Epigenetic regulation in bacterial infections: targeting histone deacetylases
Grabiec, A. M., & Potempa, J. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1373063 · Cited by 119 · see citing works
The Emerging Role of Epigenetics in Inflammation and Immunometabolism
Raghuraman, S., Donkin, I., Versteyhe, S., Barrès, R., & Simar, D. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.008 · Cited by 117 · see citing works
de Groot, A. E., & Pienta, K. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24556 · Cited by 122 · see citing works
Mukherjee, K., Fischer, R., & Vilcinskas, A. (2012) · Frontiers in Zoology · doi:10.1186/1742-9994-9-25 · Cited by 116 · see citing works
Gupta, K. D., Shakespear, M. R., Iyer, A., Fairlie, D. P., & Sweet, M. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.46 · Cited by 115 · see citing works
Ciarlo, E., Heinonen, T., Herderschee, J., Fenwick, C. W., Mombelli, M., Roy, D. L., & Roger, T. (2016) · Scientific Reports · doi:10.1038/srep37944 · Cited by 119 · see citing works
Self-citationMicrobial metabolites control gut inflammatory responses
Arpaia, N., & Rudensky, A. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323183111 · Cited by 111 · see citing works
Immunomodulatory roles of microbiota-derived short-chain fatty acids in bacterial infections
Ranjbar, R., Vahdati, S. N., Tavakoli, S., Khodaie, R., & Behboudi, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111817 · Cited by 112 · see citing works
Kapellos, T. S., & Iqbal, A. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/6591703 · Cited by 104 · see citing works
Acyldepsipeptide HDAC Inhibitor Production Induced in Burkholderia thailandensis
Biggins, J. B., Gleber, C. D., & Brady, S. F. (2011) · Organic Letters · doi:10.1021/ol200225v · Cited by 102 · see citing works
Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response
Zan, H., & Casali, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00631 · Cited by 114 · see citing works
Citrullinated histone H3: A novel target for the treatment of sepsis
Li, Y., Liu, Z., Liu, B., Zhao, T., Chong, W., Wang, Y., & Alam, H. B. (2014) · Surgery · doi:10.1016/j.surg.2014.04.009 · Cited by 100 · see citing works
Gu, L.-Z., Sun, H., & Chen, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.094 · Cited by 97 · see citing works
Shakespear, M. R., Hohenhaus, D. M., Kelly, G., Kamal, N. A., Gupta, P. K., Labzin, L. I., Schroder, K., Garceau, V., Barbero, S., Iyer, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496281 · Cited by 96 · see citing works
Gupta, K. D., Shakespear, M. R., Curson, J. E. B., Murthy, A. M. V., Iyer, A., Hodson, M. P., Ramnath, D., Tillu, V. A., von Pein, J. B., Reid, R. C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.007 · Cited by 96 · see citing works
How important are fatty acids in human health and can they be used in treating diseases?
Dicks, L. M. T. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2420765 · Cited by 97 · see citing works
den Bossche, J. V., Neele, A. E., Hoeksema, M. A., & de Winther, M. P. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000109 · Cited by 96 · see citing works
Histone Deacetylase Inhibitors Impair Antibacterial Defenses of Macrophages
Mombelli, M., Lugrin, J., Rubino, I., Chanson, A.-L., Giddey, M., Calandra, T., & Roger, T. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir553 · Cited by 89 · see citing works
Self-citationCurrent trends in protein acetylation analysis
Diallo, I., Seve, M., Cunin, V., Minassian, F., Poisson, J., Michelland, S., & Bourgoin‐Voillard, S. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1559061 · Cited by 91 · see citing works
Histones: The critical players in innate immunity
Li, X., Ye, Y., Peng, K., Zeng, Z., Chen, L., & Zeng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1030610 · Cited by 87 · see citing works
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
Kyme, P. A., Thoennissen, N. H., Tseng, C. W., Thoennissen, G. B., Wolf, A. J., Shimada, K., Krug, U. O., Lee, K., Müller‐Tidow, C., Berdel, W. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62070 · Cited by 86 · see citing works
Histone Deacetylases and Their Inhibition in Candida Species
Garnaud, C., Champleboux, M., Maubon, D., Cornet, M., & Govin, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01238 · Cited by 85 · see citing works
The role of epigenetic changes in preeclampsia
Kamrani, A., Alipourfard, I., Ahmadi‐Khiavi, H., Yousefi, M., Rostamzadeh, D., Izadi, M., & Ahmadi, M. (2019) · BioFactors · doi:10.1002/biof.1542 · Cited by 85 · see citing works
Cycon, K. A., Mulvaney, K. M., Rimsza, L. M., Persky, D. O., & Murphy, S. P. (2013) · Immunology · doi:10.1111/imm.12136 · Cited by 83 · see citing works
Kobayashi, T., Matsuoka, K., Sheikh, S. Z., Russo, S. M., Mishima, Y., Collins, C. B., de Zoeten, E. F., Karp, C. L., Ting, J. P. ‐., Sartor, R. B., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200042 · Cited by 83 · see citing works
Bandyopadhaya, A., Tsurumi, A., Maura, D., Jeffrey, K. L., & Rahme, L. G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.174 · Cited by 79 · see citing works
Cross, D. L., Drury, R. E., Hill, J. W., & Pollard, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01363 · Cited by 81 · see citing works
Zhou, R., Gong, A., Chen, D., Miller, R. E., Eischeid, A. N., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065153 · Cited by 77 · see citing works
Epigenetics in sepsis: targeting histone deacetylases.
Ciarlo, E., Savva, A., & Roger, T. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.004 · Cited by 72 · see citing works
Self-citationRegulation of Immune Responses by Histone Deacetylase Inhibitors
Licciardi, P. V., & Karagiannis, T. C. (2012) · ISRN Hematology · doi:10.5402/2012/690901 · Cited by 75 · see citing works
Corrêa, R. O., Vieira, A. T., Sernaglia, E. M., Lancellotti, M., Vieira, A. T., Ávila-Campos, M. J., Rodrigues, H. G., & Vinolo, M. A. R. (2017) · Cellular Microbiology · doi:10.1111/cmi.12720 · Cited by 75 · see citing works
Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
Li, W., & Sun, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071616 · Cited by 77 · see citing works
Wu, J., Dong, L., Zhang, M., Jia, M., Zhang, G., Qiu, L., Ji, M., & Yang, J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1159-0 · Cited by 73 · see citing works
Roger, T., Delaloye, J., Chanson, A.-L., Giddey, M., Roy, D. L., & Calandra, T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis673 · Cited by 73 · see citing works
Self-citationNair, V. S., Saleh, R., Toor, S. M., Taha, R. Z., Ahmed, A., Kurer, M. A., Murshed, K., Alajez, N. M., Nada, M. A., & Elkord, E. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0808-9 · Cited by 72 · see citing works
Cole, J., Aberdein, J., Jubrail, J., & Dockrell, D. H. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.004 · Cited by 69 · see citing works
Zhang, H., Du, ., Yang, Q., & Zhu, M. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.09.020 · Cited by 72 · see citing works
Liu, M., Zhou, J., Chen, Z., & Cheng, A. S. L. (2016) · The Journal of Pathology · doi:10.1002/path.4832 · Cited by 71 · see citing works
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.96 · Cited by 71 · see citing works
Epigenomic regulation of host–microbiota interactions
Alenghat, T., & Artis, D. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.007 · Cited by 70 · see citing works
Kelly‐Sell, M. J., Kim, Y. H., Straus, S., Benoit, B. M., Harrison, C., Sutherland, K., Armstrong, R. J., Weng, W., Showe, L. C., Wysocka, M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23112 · Cited by 70 · see citing works
Inhibiting epigenetic enzymes to improve atherogenic macrophage functions
den Bossche, J. V., Neele, A. E., Hoeksema, M. A., de Heij, F., Boshuizen, M. C. S., van der Velden, S., de Boer, V. C. J., Reedquist, K. A., & de Winther, M. P. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.029 · Cited by 70 · see citing works
Chaix, R., Fagny, M., Cosín‐Tomás, M., Alvarez-López, M., Lemée, L., Regnault, B., Davidson, R. J., Antoine Lutz, A., & Kaliman, P. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.11.003 · Cited by 74 · see citing works
EZH2 in Bladder Cancer, a Promising Therapeutic Target
Martínez‐Fernández, M., Rubio, C., Segovia, C., López-Calderón, F., Dueñas, M., & Paramio, J. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126000 · Cited by 67 · see citing works
Lugrin, J., Ciarlo, E., Santos, A., Grandmaison, G., Dos Santos, I., Le Roy, D., & Roger, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.004 · Cited by 67 · see citing works
Self-citationThe Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67 · see citing works
Soria-Castro, R., Schcolnik‐Cabrera, A., Rodríguez-López, G. M., Campillo-Navarro, M., Puebla‐Osorio, N., Estrada-Parra, S. A., Estrada‐García, I., Chacón‐Salinas, R., & Chávez-Blanco, A. D. (2019) · Journal of Immunology Research · doi:10.1155/2019/9678098 · Cited by 68 · see citing works
Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection
Seshadri, C., Sedaghat, N., Campo, M., Peterson, G. J., Wells, R. D., Olson, G. S., Sherman, D. R., Stein, C. M., Mayanja‐Kizza, H., Shojaie, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175844 · Cited by 65 · see citing works
Histone Deacetylase Inhibitors as Immunomodulators in Cancer Therapeutics
Shen, L., Orillion, A. R., & Пили, Р. (2016) · Epigenomics · doi:10.2217/epi.15.118 · Cited by 66 · see citing works
Metabolism and acetylation in innate immune cell function and fate
Cameron, A. M., Lawless, S. J., & Pearce, E. J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.003 · Cited by 64 · see citing works
Toussirot, É., Abbas, W., Khan, K. A., Tissot, M., Jeudy, A., Baud, L., Bertolini, E., Wendling, D., & Herbein, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070939 · Cited by 63 · see citing works
Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model
Li, Y., Zhao, T., Liu, B., Halaweish, I. F., Mazitschek, R., Duan, X., & Alam, H. B. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000510 · Cited by 63 · see citing works
Ariffin, J. K., Gupta, K. D., Kapétanovic, R., Iyer, A., Reid, R. C., Fairlie, D. P., & Sweet, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01876-15 · Cited by 63 · see citing works
Moores, R., Brilha, S., Schutgens, F., Elkington, P. T., & Friedland, J. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00602 · Cited by 61 · see citing works
Promising targets based on pattern recognition receptors for cancer immunotherapy
Bai, L., Li, W., Zheng, W., Xu, D., Chen, N., & Cui, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105017 · Cited by 63 · see citing works
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats
Tan, L., Zhang, Y., Han, D., Hua, R., Guo, B., Hu, S.-Q., Yan, X., & Xu, T. J. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8468-4 · Cited by 61 · see citing works
- Authors
- Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P., & Calandra, T.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland;
- University Hospital of Geneva (CH)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-01-27
- Volume
- 117
- Issue
- 4
- Pages
- 1205-1217
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2066887945
- Cited by
- 341
- References
- 51
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 13 · 2023: 17 · 2022: 23 · 2021: 23 · 2020: 26 · 2019: 18 · 2018: 24 · 2017: 23 · 2016: 38 · 2015: 23 · 2014: 28 · 2013: 28 · 2012: 24
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase inhibitors, innate immunity, TLR agonists, macrophages, dendritic cells, histone acetylation, epigenetic regulation, NuRD complex, host defense genes, cytokine production, bacterial infection susceptibility, fungal infection susceptibility, septic shock, pattern recognition receptors
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Drug Evaluation, Preclinical, Female, Gene Expression Regulation, Humans, Immunity, Innate, Infections, Macrophages, Mice, Inbred BALB C, Down-Regulation, Gene Expression Profiling, Microarray Analysis, Toll-Like Receptors, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
